Clinical Trials on Capacity Building in Singapore
Total 0 results
Nothing found
Sponsors and Collaborators
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Plethora Solutions Ltd
- S-Biotek Holding ApS
- Oblikue Consulting
- Paulo Sérgio Gomes Nogueira Borges
- Eurotrials Brasil Consultores Cientificos Ltda
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Iyad Naeem Muhammad, PhD
- Rivierduinen, Centre for Personality disorders Jelgersma
- Julian Taylor Green
- United States Department of Defense (DOD)
- Arsha Vidya Tirtha
- Foshan Sanshui District People's Hospital
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Gunkang Pharmaceuticals, Inc
- University of Applied Sciences Jena
- Lilly PharmaceuticalCompany
- Sudimplant SAS - Groupe TBR
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Korea Otsuka International Asia Arab
- View Full List
Medical Conditions
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Vibration; Exposure
- Malaria,Falciparum
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Chemotherapy-Induced Neutropenia
- Advance Directive Completion
- Hypothermia Following Anesthesia, Sequela
- Immunologically-induced Lung Disease
- Huntington Chorea
- Puberty, Delayed
- Anemia Acute
- Serum Albumin Low
- Blepharospasm of Both Eyelids
- Visual Attention Span Deficit
- Deformity Flexion
- Brain Tumor, Primary
- Thyroid and Parathyroid Surgery
- Testicular Teratoma
- Gray Platelet Syndrome
- View Full List
Drug Interventions
- S-Adenosyl-Methionine
- Furmonertinib 160 mg
- MMV390048 120mg
- Pegfilgrastim
- Sorafenib
- Cyanoacrylate
- Mineralocorticoid receptor antagonist
- Acalabrutinib in combination with VR
- Rovalpituzumab tesirine
- Cytisine
- Standard medical therapy
- Oxycodone
- F520
- ABY-035 i.v.
- Ebselen
- Vosaroxin
- Bimatoprost 0.03% eye drops
- Celecoxib
- Pemetrexed
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Austria
- Contract Research Organizations in Croatia
- Contract Research Organizations in Egypt
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in France
- Contract Research Organizations in Gambia
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Morocco
- Contract Research Organizations in Poland
- Contract Research Organizations in Qatar
- Contract Research Organizations in Togo
- CRO list by country